| A policy case study of blood in Australia. | |
| | |
MedLine Citation:
|
PMID: 20843593 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In 2008 the Australian government decided to remove white blood cells from all blood products. This policy of universal leucodepletion was a change to the existing policy of supplying leucodepleted products to high risk patients only. The decision was made without strong information about the cost-effectiveness of universal leucodepletion. The aims for this policy analysis are to generate cost-effectiveness data about universal leucodepletion, and to add to our understanding of the role of evidence and the political reality of healthcare decision-making in Australia. The cost-effectiveness analysis revealed universal leucodepletion costs $398,943 to save one year of life. This exceeds the normal maximum threshold for Australia. We discuss this result within the context of how policy decisions are made about blood, and how it relates to the theory and process of policy making. We conclude that the absence of a strong voice for cost-effectiveness was an important omission in this decision. |
| | |
Authors:
|
Nicholas Graves; Gina Clare; Mary Haines; Robert Bird |
Related Documents
:
|
10686063 - Sixth epfa/nibsc workshop on nat in rome 1999: outcome of discussions. 14690063 - The spectrum of safety: a review of the safety of current hemophilia products. 3764963 - Transcranial doppler measurement of middle cerebral artery blood flow velocity: a valid... |
Publication Detail:
|
Type: Journal Article Date: 2010-08-26 |
Journal Detail:
|
Title: Social science & medicine (1982) Volume: 71 ISSN: 1873-5347 ISO Abbreviation: Soc Sci Med Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-10-11 Completed Date: 2010-12-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8303205 Medline TA: Soc Sci Med Country: England |
Other Details:
|
Languages: eng Pagination: 1677-82 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Queensland University of Technology, Australia. n.graves@qut.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Australia Cost-Benefit Analysis Decision Making* Health Policy* / economics Humans Leukocyte Reduction Procedures / economics* Organizational Case Studies Policy Making Politics* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrol...
Next Document: Passive leg raising during cardiopulmonary resuscitation in out-of-hospital cardiac arrest--does it ...